Novo Nordisk
26 stories
-
financeNovo Nordisk Boosts Irish Tablet Plant with €432 Million Investment
Novo Nordisk invests €432 million in its Athlone, Ireland facility to expand manufacturing capacity for oral GLP-1 therapies, meeting growing global demand.
-
healthNovo Nordisk Slashes Ozempic & Wegovy Prices Amid Fierce Competition
Novo Nordisk announces significant list price reductions for Ozempic and Wegovy, aiming to boost affordability for insured patients amidst rising competition and market pressures.